Ambee Pharmaceuticals (DHA:AMBEEPHA) Non Operating Income: BDT Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT731.90
View Full Analysis

What is Ambee Pharmaceuticals Non Operating Income?

Ambee Pharmaceuticals DHA:AMBEEPHA -0.03% 18 Non Operating Income is BDT Mil as of . 20. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100.

Non Operating Income is income or expense that comes from miscellaneous sources. Ambee Pharmaceuticals's Non Operating Income for the three months ended in . 20 was BDT0.00 Mil.

Ambee Pharmaceuticals Non Operating Income Related Terms

Ambee Pharmaceuticals Non Operating Income Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Non Operating Income Chart

Ambee Pharmaceuticals Annual Data
Trend
Non Operating Income

Ambee Pharmaceuticals Quarterly Data
Non Operating Income
DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of BDT Mil mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a Non Operating Income of BDT Mil as of . 20. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Ambee Pharmaceuticals and its competitors.
Is Ambee Pharmaceuticals' Non Operating Income too high?
Ambee Pharmaceuticals' current Non Operating Income is BDT Mil. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' Non Operating Income compare to IMNPQ?
Ambee Pharmaceuticals' Non Operating Income of BDT Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Drug Manufacturers company?
A good Non Operating Income depends on the Drug Manufacturers industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current Non Operating Income is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current Non Operating Income of BDT Mil. The current Non Operating Income is BDT Mil. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current Non Operating Income is BDT Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT731.90
Price